Pharmacological therapy of abdominal aortic aneurysm: an update
Y Wang, Z Liu, J Ren, M Xiang - Current vascular …, 2018 - ingentaconnect.com
Background: Abdominal aortic aneurysm (AAA), a progressive segmental abdominal aortic
dilation, is associated with high mortality. AAA is characterized by inflammation, smooth …
dilation, is associated with high mortality. AAA is characterized by inflammation, smooth …
Pathogenesis and management of abdominal aortic aneurysm
J Golledge, S Thanigaimani, JT Powell… - European Heart …, 2023 - academic.oup.com
Abdominal aortic aneurysm (AAA) causes∼ 170 000 deaths annually worldwide. Most
guidelines recommend asymptomatic small AAAs (30 to< 50 mm in women; 30 to< 55 mm in …
guidelines recommend asymptomatic small AAAs (30 to< 50 mm in women; 30 to< 55 mm in …
[HTML][HTML] Development of pharmacotherapies for abdominal aortic aneurysms
The cardiovascular field is still searching for a treatment for abdominal aortic aneurysms
(AAA). This inflammatory disease often goes undiagnosed until a late stage and associated …
(AAA). This inflammatory disease often goes undiagnosed until a late stage and associated …
[HTML][HTML] Novel pharmacological approaches in abdominal aortic aneurysm
L Puertas-Umbert, R Almendra-Pegueros… - Clinical …, 2023 - portlandpress.com
Abdominal aortic aneurysm (AAA) is a severe vascular disease and a major public health
issue with an unmet medical need for therapy. This disease is featured by a progressive …
issue with an unmet medical need for therapy. This disease is featured by a progressive …
Current status and perspectives on pharmacologic therapy for abdominal aortic aneurysm
K Yoshimura, N Morikage… - Current drug …, 2018 - ingentaconnect.com
Background: Abdominal aortic aneurysm (AAA), a common disease involving the segmental
expansion and rupture of the aorta, has a high mortality rate. Therapeutic options for AAA …
expansion and rupture of the aorta, has a high mortality rate. Therapeutic options for AAA …
Research advances in drug therapy for abdominal aortic aneurysms over the past five years: An updated narrative review
R Li, Y Liu, J Jiang - International Journal of Cardiology, 2023 - Elsevier
Background Abdominal aortic aneurysms (AAA) rupture can lead to patient death. Surgical
treatment is currently the optimal treatment for AAA with large diameter (≥ 50 mm). For AAA …
treatment is currently the optimal treatment for AAA with large diameter (≥ 50 mm). For AAA …
[HTML][HTML] Challenges and opportunities in limiting abdominal aortic aneurysm growth
J Golledge, PE Norman, MP Murphy… - Journal of vascular …, 2017 - Elsevier
Objective This review describes ongoing efforts to develop a medical therapy to limit
abdominal aortic aneurysm (AAA) growth. Methods Data from animal model studies, human …
abdominal aortic aneurysm (AAA) growth. Methods Data from animal model studies, human …
Lack of an effective drug therapy for abdominal aortic aneurysm
Abdominal aortic aneurysm (AAA) rupture is a common cause of death in adults. Current
AAA treatment is by open surgical or endovascular aneurysm repair. Rodent model and …
AAA treatment is by open surgical or endovascular aneurysm repair. Rodent model and …
Current evidence and prospects for medical treatment of abdominal aortic aneurysms
Diehm, Schmidli, Dai-Do, Baumgartner - Vasa, 2005 - econtent.hogrefe.com
Abdominal aortic aneurysm (AAA) is a potentially fatal condition with risk of rupture
increasing as maximum AAA diameter increases. It is agreed upon that open surgical or …
increasing as maximum AAA diameter increases. It is agreed upon that open surgical or …
Targets for medical therapy to limit abdominal aortic aneurysm progression
TI Emeto, SW Seto, J Golledge - Current drug targets, 2014 - ingentaconnect.com
Abdominal aortic aneurysm (AAA) is an important cause of mortality in older adults. Most
AAAs are asymptomatic and screening programs have been introduced to identify AAAs at …
AAAs are asymptomatic and screening programs have been introduced to identify AAAs at …